Navigation Links
Aware, Inc. Announces Preliminary Results of Dutch Auction Tender Offer
Date:4/20/2009

www.aware.com

Forward-Looking Statements

This press release contains forward-looking statements, including, among others, statements relating to the results of the tender offer. These statements, including their underlying assumptions, are subject to risks and uncertainties and are not guarantees of future performance. Results may differ materially due to various factors such as an unexpected number of shares improperly tendered or withdrawn or other variations in the depositary's preliminary count statements regarding the expected number of shares to be purchased, the proration factor, and the price per share. For further details of these risks, you should read our filings with the Securities and Exchange Commission related to the tender offer, including our Schedule TO and the documents referred to therein.

The statements presented in this press release speak only as of the date of the release. Please note that except as required by applicable law we undertake no obligation to revise or update publicly any forward-looking statements for any reason.

Aware, Dr. DSL and StratiPHY are trademarks or registered trademarks of Aware, Inc.

Any other trademarks appearing herein are the property of their respective owners.


'/>"/>
SOURCE Aware, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. Aware, Inc. Introduces Biometrics Software for Tenprint Autocapture
2. Aware, Inc. Announces Richard Moberg to Return as CFO
3. Aware, Inc. Reports Fourth Quarter and 2007 Financial Results
4. Sun Microsystems and Aware, Inc. Announce Integration of Awares BioSP with Sun Identity Management Solutions
5. Aware, Inc. Reports Fourth Quarter and 2008 Financial Results
6. Aware, Inc. Commences Dutch Auction Tender Offer
7. Aware, Inc. Commences Dutch Auction Tender Offer
8. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
9. Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines
10. LaserCard Corporation Announces Expansion of Middle East Project
11. BIO-key(R) Announces Contracts for New Criminal Justice Data Sharing Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 2014) Scientists at The New York Stem ... closer to creating a viable cell replacement therapy ... , For the first time, NYSCF scientists ... skin samples of patients with primary progressive multiple ... to induce these stem cells into becoming oligodendrocytes, ...
(Date:7/24/2014)... 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced ... control Phase 3 study of Zerenex (ferric citrate), the ... treatment of hyperphosphatemia in patients with end-stage renal disease ... iRon delivery with FErric CiTrate in EsrD) was published ... Society of Nephrology ( JASN ). ...
(Date:7/24/2014)... YORK, NY (July 24, 2014) Scientists at ... Institute are one step closer to creating a ... a patient,s own cells. , For the ... (iPS) cells lines from skin samples of patients ... developed an accelerated protocol to induce these stem ...
Breaking Biology News(10 mins):NYSCF scientists one step closer to cell therapy for multiple sclerosis patients 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2
... directed by Scripps Research Professor Benjamin Cravatt, Ph.D., ... of The Journal of Biological Chemistry. , The ... previously suggested-for the biosynthesis of neurotransmitter lipids, N-acyl ... anandamide. The high activity of the enzyme a/b ...
... within the cell nucleus and performs one of the ... machines that convert the genetic information carried by messenger ... , Gary Karpen and Jamy Peng, researchers in ... Lawrence Berkeley National Laboratory, have now discovered two pathways ...
... Scripps Research Professor Benjamin Cravatt, Ph.D., is being ... Journal of Biological Chemistry. , The new study ... the biosynthesis of neurotransmitter lipids, N-acyl ethanolamines (NAEs), ... high activity of the enzyme a/b hydrolase4 (Abh4) ...
Cached Biology News:Nanotechnology propels advances in regenerative medicine research 2Regulating the nuclear architecture of the cell 2Regulating the nuclear architecture of the cell 3Regulating the nuclear architecture of the cell 4Regulating the nuclear architecture of the cell 5Brown seaweed contains promising fat fighter, weight reducer 2
(Date:7/25/2014)... Pittsburgh, PA (PRWEB) July 25, 2014 ... annual Call for Topics for Conferee Networking. These two-hour ... similar interests to meet and resolve problems, discuss new ... , The deadline to submit a topic for consideration ... at pittcon.org . The Conferee Networking committee will ...
(Date:7/25/2014)... Biotech Ltd. (Nasdaq: SVA ), a leading provider ... announced that it will release its unaudited financial results for ... on Thursday, August 14, 2014 EDT. The Company will host ... August 15, 2014, at 8:00 a.m. EDT (Friday, August 15, ... Company,s financial results and provide an update on recent corporate ...
(Date:7/24/2014)... 24, 2014  Asterias Biotherapeutics, Inc. (OTCBB: ASTYV), ... of regenerative medicine, announced today that it will ... investors on Tuesday, July 29, 2014, at 4:30 ... include an overview of Asterias, business strategy and ... http://www.ustream.tv/channel/asterias-biotherapeutics at least 15 minutes before ...
(Date:7/24/2014)... Yushan Yan, Distinguished Professor of Engineering at the ... nanomaterials to solve problems in energy engineering, environmental ... focused on zeolites, porous rock with a well-defined, ... size is so precisely decided that zeolites can ... fraction of an angstrom (one-tenth of a nanometer), ...
Breaking Biology Technology:Pittcon 2015 Announces Call for Topics for Conferee Networking Sessions 2Sinovac to Host Conference Call to Report Second Quarter 2014 Unaudited Financial Results 2Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4University of Delaware researcher describes new approach for creating organic zeolites 2
... (TCI), a Los,Angeles-based DNA and genomics research and ... office in the heart of Boston,s legal and,financial ... of,chemical and toxic exposures on human health and ... Consulting, TCI now offers a,range of business, financial, ...
... Watson,Pharmaceuticals, Inc. (NYSE: WPI ), a leading ... will provide an,overview of the Company,s business at ... September 10, 2007 at 3:30 p.m. Eastern,Daylight Time. ... can be accessed on Watson,Pharmaceuticals, Investor Relations Web ...
... INDIANAPOLIS and SOUTH SAN FRANCISCO, Calif., Sept. 4, ... Dow Chemical Company (NYSE: DOW ), and ... Inc. (Nasdaq: EXEL ), announced today,that the ... includes the purchase of selected assets by Dow ...
Cached Biology Technology:Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases 2Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation 2Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation 3
... ZMD.473. Immunogen: Synthetic peptide derived ... mouse junctophilin-2. Specificity: Specific for ... (positive controls: mouse skeletal muscle homogenates ... Applications: Western blotting Immunohistochemistry(froz) ImmunofluorescenceStorage: Store ...
Laminin gamma-2 (G-16)...
ABIN-2 Polyclonal Ab 100 ug rabbit polyclonal antibody. Detects ABIN-2 in human/mouse. Tested in WB....
Syd-2 (cL-19)...
Biology Products: